Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand's syndrome. Seven new cases with a literature review

Joint Bone Spine

Volumn 69, Issue 1, 2002, Pages 62-67

  Lamboley, V ^a   Zabraniecki, Laurent ^a   Sie, P ^a   Pourrat, J ^a   Fournié, Bernard ^a  

^a CHU PURPAN   (France)

Author keywords

Acquired von Willebrand's syndrome; Monoclonal gammopathy; Myeloma

Indexed keywords

ANTINEOPLASTIC AGENT; DESMOPRESSIN; DEXAMETHASONE; DOXORUBICIN; ENDOBULINE; IMMUNOGLOBULIN; MELPHALAN; PREDNISONE; SANDOGLOBULINE; VINCRISTINE; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIODYSPLASIA; ARTICLE; BLEEDING; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; HUMAN; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MYELOMA; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; SYMPTOM; VON WILLEBRAND DISEASE;

EID: 0036158553     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(01)00343-8     Document Type: Article

References (27)

1. Acquired von Willebrand's syndrome in systemic lupus erythematosus
2. Acquired von Willebrand's disease: A concise review
3. Acquired von Willebrand syndrome: Data from an international registry
4. Von Willebrand factor-structure and function
5. Association maladie de Willebrand acquise-gammapathie monoclonale-angiodysplasie du grêle: Une indication rare des immunoglobulines intraveineuses à forte dose
6. Acquired von Willebrand disease: Concise review of occurrence, diagnosis, pathogenesis, and treatment
7. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: Comparison of three different therapeutic approaches
8. Clinical significance of inhibitors in acquired von Willebrand syndrome
9. Acquired von Willebrand syndrome: From pathophysiology to management
10. Acquired von Willebrand's disease, platelet-release defect and angiodysplasia
11. Gastro-intestinal bleeding in acquired von Willebrand's disease: Efficacy of high-dose immunoglobulin where substitution treatments failed
12. À propos de l'association entre maladie de Willebrand et angiodysplasie
13. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis
14. Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells
15. Quatre cas de déficit acquis en facteur Willebrand associés à une dysglobulinémie monoclonale
16. Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor
17. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor
18. Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells
19. Efficacy of high-dose intravenous gammaglobulin in the management of acquired von Willebrand's disease during orthopaedic surgery
20. Acquired von Willebrand disease associated with multiple myeloma; characterization of an inhibitor to von Willebrand factor
21. DDAVP in acquired von Willebrand syndrome associated with multiple myeloma
22. The use of high-dose intravenous gammaglobulin in acquired von Willebrand syndrome
23. Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate
24. Acquired von Willebrand disease: Correction of hemostatic defect by high-dose intravenous immunoglobulins
25. High-dose intravenous immunoglobulin delays clearance of Willebrand factor in acquired von Willebrand disease